The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) are tracking and studying a highly mutated new variant of the virus that causes COVID-19. Officially titled BA.2.86 and nicknamed Pirola on social media, the WHO has designated it as a “variant under monitoring.” This status applies to variants that have an unusually large number of mutations that call for monitoring as they spread.
According to Fred Hutchinson Cancer Center evolutionary biologist Jesse Bloom, BA.2.86 has more than 30 amino acid changes in its spike protein, compared with its next closest ancestor (Omicron’s BA.2 subvariant).
“We have not seen a new variant [in humans] with this many new spike mutations happening all at once since the emergence of the original Omicron,” Bloom told NBC News. “Based on the sequence, I think we can be very confident this [variant] is going to be relatively good at evading the antibodies that most people have from prior infections and vaccinations. What we still don’t know is, is this variant good enough at transmitting that it will really be able to spread widely around the world?”
So far, only six sequences BA.2.86 have been reported in the United States, United Kingdom, Israel, and Denmark, but epidemiologists are concerned that it is circulating in more places since monitoring COVID-19 variants has dropped.
“It is unusual for corona to change so significantly and develop 30 new mutations. The last time we saw such a big change was when Omicron appeared,” Morten Rasmussen, a senior researcher at the Statens Serum Institut (SSI) in Denmark, said in a statement.
SSI scientists stressed that it is currently too early to say if this new variant is more contagious or severe and that they are in the process testing it against human antibodies.
The CDC will keep monitoring BA.2.86, but did not say it is not currently a cause for alarm. According to the CDC’s variant tracker, the XBB descendant EG.5 (nicknamed Eris) is causing roughly 20 percent of all new COVID-19 cases in the US and is the dominant variant. The next most common variant is FL.1.5.1, causing about 13 percent new cases.
[Related: Your guide to COVID testing for the unforeseeable future.]
“I think what we are seeing is our detection mechanisms that we’ve put in place are working, right?” CDC Director Mandy Cohen told CNN. “We are more prepared than ever to detect and respond to changes in the COVID-19 virus.”
As the fall and winter virus season approaches, COVID-19 cases are expected to continue to climb around the US. The Food and Drug Administration (FDA) is expected to authorize updated booster shots soon, with signoff from the CDC expected by mid-September. The new boosters won’t include the specific EG.5 subvariant or BA.2.86, but will target the XBB strains.
News
New nanomedicine wipes out leukemia in animal study
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic. In the new study, [...]
Mystery Solved: Scientists Find Cause for Unexplained, Deadly Diseases
A study reveals that a protein called RPA is essential for maintaining chromosome stability by stimulating telomerase. New findings from the University of Wisconsin-Madison suggest that problems with a key protein that helps preserve chromosome stability [...]
Nanotech Blocks Infection and Speed Up Chronic Wound Recovery
A new nanotech-based formulation using quercetin and omega-3 fatty acids shows promise in halting bacterial biofilms and boosting skin cell repair. Scientists have developed a nanotechnology-based treatment to fight bacterial biofilms in wound infections. The [...]
Researchers propose five key questions for effective adoption of AI in clinical practice
While Artificial Intelligence (AI) can be a powerful tool that physicians can use to help diagnose their patients and has great potential to improve accuracy, efficiency and patient safety, it has its drawbacks. It [...]
Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment
A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment. This paper presents an exhaustive overview of subtype-specific nanostrategies, the clinical benefits [...]
It’s Not “All in Your Head”: Scientists Develop Revolutionary Blood Test for Chronic Fatigue Syndrome
A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers from the University of East Anglia and Oxford Biodynamics have created a highly accurate [...]
How Far Can the Body Go? Scientists Find the Ultimate Limit of Human Endurance
Even the most elite endurance athletes can’t outrun biology. A new study finds that humans hit a metabolic ceiling at about 2.5 times their resting energy burn. When ultra-runners take on races that last [...]
World’s Rivers “Overdosing” on Human Antibiotics, Study Finds
Researchers estimate that approximately 8,500 tons of antibiotics enter river systems each year after passing through the human body and wastewater treatment processes. Rivers spanning millions of kilometers across the globe are contaminated with [...]
Yale Scientists Solve a Century-Old Brain Wave Mystery
Yale scientists traced gamma brain waves to thalamus-cortex interactions. The discovery could reveal how brain rhythms shape perception and disease. For more than a century, scientists have observed rhythmic waves of synchronized neuronal activity [...]
Can introducing peanuts early prevent allergies? Real-world data confirms it helps
New evidence from a large U.S. primary care network shows that early peanut introduction, endorsed in 2015 and 2017 guidelines, was followed by a marked decline in clinician-diagnosed peanut and overall food allergies among [...]
Nanoparticle blueprints reveal path to smarter medicines
Lipid nanoparticles (LNPs) are the delivery vehicles of modern medicine, carrying cancer drugs, gene therapies and vaccines into cells. Until recently, many scientists assumed that all LNPs followed more or less the same blueprint, [...]
How nanomedicine and AI are teaming up to tackle neurodegenerative diseases
When I first realized the scale of the challenge posed by neurodegenerative diseases, such as Alzheimer's, Parkinson's disease and amyotrophic lateral sclerosis (ALS), I felt simultaneously humbled and motivated. These disorders are not caused [...]
Self-Organizing Light Could Transform Computing and Communications
USC engineers have demonstrated a new kind of optical device that lets light organize its own route using the principles of thermodynamics. Instead of relying on switches or digital control, the light finds its own [...]
Groundbreaking New Way of Measuring Blood Pressure Could Save Thousands of Lives
A new method that improves the accuracy of interpreting blood pressure measurements taken at the ankle could be vital for individuals who are unable to have their blood pressure measured on the arm. A newly developed [...]
Scientist tackles key roadblock for AI in drug discovery
The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high potency, selectivity, and favorable metabolic properties—at the earliest stages is important for reducing cost and accelerating the path [...]
Nanoplastics with environmental coatings can sneak past the skin’s defenses
Plastic is ubiquitous in the modern world, and it's notorious for taking a long time to completely break down in the environment - if it ever does. But even without breaking down completely, plastic [...]
